BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 23768641)

  • 1. Molecular underpinning of extranodal NK/T-cell lymphoma.
    Huang Y; de Leval L; Gaulard P
    Best Pract Res Clin Haematol; 2013 Mar; 26(1):57-74. PubMed ID: 23768641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus-associated natural killer/T-cell lymphomas.
    Asano N; Kato S; Nakamura S
    Best Pract Res Clin Haematol; 2013 Mar; 26(1):15-21. PubMed ID: 23768637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HACE1, a potential tumor suppressor gene on 6q21, is not involved in extranodal natural killer/T-cell lymphoma pathophysiology.
    Sako N; Dessirier V; Bagot M; Bensussan A; Schmitt C
    Am J Pathol; 2014 Nov; 184(11):2899-907. PubMed ID: 25203537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New biomarkers in T-cell lymphomas.
    Bisig B; Gaulard P; de Leval L
    Best Pract Res Clin Haematol; 2012 Mar; 25(1):13-28. PubMed ID: 22409820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous peripheral T-cell lymphoma of cytotoxic phenotype mimicking extranodal NK/T-cell lymphoma.
    Pan ST; Chang WS; Murphy M; Martinez A; Chuang SS
    Am J Dermatopathol; 2011 Apr; 33(2):e17-20. PubMed ID: 21252637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATP-binding cassette sub-family C member 4 (ABCC4) is overexpressed in human NK/T-cell lymphoma and regulates chemotherapy sensitivity: Potential as a functional therapeutic target.
    Zhang X; Zhao L; Li X; Wang X; Li L; Fu X; Sun Z; Li Z; Nan F; Chang Y; Zhang M
    Leuk Res; 2015 Dec; 39(12):1448-54. PubMed ID: 26499190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic protein expression in natural killer cell lymphomas and in alpha beta and gamma delta peripheral T-cell lymphomas.
    Boulland ML; Kanavaros P; Wechsler J; Casiraghi O; Gaulard P
    J Pathol; 1997 Dec; 183(4):432-9. PubMed ID: 9496260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nodal cytotoxic molecule (CM)-positive Epstein-Barr virus (EBV)-associated peripheral T cell lymphoma (PTCL): a clinicopathological study of 26 cases.
    Kato S; Takahashi E; Asano N; Tanaka T; Megahed N; Kinoshita T; Nakamura S
    Histopathology; 2012 Aug; 61(2):186-99. PubMed ID: 22690710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profiling.
    Ng SB; Selvarajan V; Huang G; Zhou J; Feldman AL; Law M; Kwong YL; Shimizu N; Kagami Y; Aozasa K; Salto-Tellez M; Chng WJ
    J Pathol; 2011 Mar; 223(4):496-510. PubMed ID: 21294123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathology and biology of peripheral T-cell lymphomas.
    de Leval L; Gaulard P
    Histopathology; 2011 Jan; 58(1):49-68. PubMed ID: 21261683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro.
    Iqbal J; Weisenburger DD; Chowdhury A; Tsai MY; Srivastava G; Greiner TC; Kucuk C; Deffenbacher K; Vose J; Smith L; Au WY; Nakamura S; Seto M; Delabie J; Berger F; Loong F; Ko YH; Sng I; Liu X; Loughran TP; Armitage J; Chan WC;
    Leukemia; 2011 Feb; 25(2):348-58. PubMed ID: 21052088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between higher expression of YB-1 and poor prognosis in early-stage extranodal nasal-type natural killer/T-cell lymphoma.
    Zhao Z; Liao Y; Li J; Wu J; Zhang Y; Feng G; Tan B; Reng S; Zhang Z; Feng X; Wang J; Du X
    Biomark Med; 2014; 8(4):581-8. PubMed ID: 24796623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type.
    Huang Y; de Reyniès A; de Leval L; Ghazi B; Martin-Garcia N; Travert M; Bosq J; Brière J; Petit B; Thomas E; Coppo P; Marafioti T; Emile JF; Delfau-Larue MH; Schmitt C; Gaulard P
    Blood; 2010 Feb; 115(6):1226-37. PubMed ID: 19965620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypermethylation of PRDM1/Blimp-1 promoter in extranodal NK/T-cell lymphoma, nasal type: an evidence of predominant role in its downregulation.
    Zhang Z; Liang L; Li D; Nong L; Liu J; Qu L; Zheng Y; Zhang B; Li T
    Hematol Oncol; 2017 Dec; 35(4):645-654. PubMed ID: 27704586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular pathogenesis of peripheral T cell lymphoma (2): extranodal NK/T cell lymphoma, nasal type, adult T cell leukemia/lymphoma and enteropathy associated T cell lymphoma].
    Couronné L; Bastard C; Gaulard P; Hermine O; Bernard O
    Med Sci (Paris); 2015 Nov; 31(11):1023-33. PubMed ID: 26576610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NK and NK-like T-cell lymphoma in extranasal sites: a comparative clinicopathological study according to site and EBV status.
    Ko YH; Cho EY; Kim JE; Lee SS; Huh JR; Chang HK; Yang WI; Kim CW; Kim SW; Ree HJ
    Histopathology; 2004 May; 44(5):480-9. PubMed ID: 15139996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study in multiple populations.
    Lin GW; Xu C; Chen K; Huang HQ; Chen J; Song B; Chan JKC; Li W; Liu W; Shih LY; Chuang WY; Kim WS; Tan W; Peng RJ; Laurensia Y; Cheah DMZ; Huang D; Cheng CL; Su YJ; Tan SY; Ng SB; Tang TPL; Han K; Wang VY; Jia WH; Pei Z; Li YJ; Gao S; Shi Y; Hu Z; Zhang F; Zhang B; Zeng YX; Shen H; He L; Ong CK; Lim ST; Chanock S; Kwong YL; Lin D; Rothman N; Khor CC; Lan Q; Bei JX;
    Lancet Oncol; 2020 Feb; 21(2):306-316. PubMed ID: 31879220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International analysis of the frequency and outcomes of NK/T-cell lymphomas.
    William BM; Armitage JO
    Best Pract Res Clin Haematol; 2013 Mar; 26(1):23-32. PubMed ID: 23768638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extranodal NK/T-cell lymphoma: toward the identification of clinical molecular targets.
    Schmitt C; Sako N; Bagot M; Huang Y; Gaulard P; Bensussan A
    J Biomed Biotechnol; 2011; 2011():790871. PubMed ID: 21541194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical management of natural killer/T-cell lymphoma.
    Tse E; Kwong YL
    Curr Opin Oncol; 2012 Sep; 24(5):480-6. PubMed ID: 22691924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.